Centre Hospitalier General De Soissons
- Address
- 46 Avenue Du General De Gaulle, 02200 Soissons, France
Centre Hospitalier General De Soissons - Infectious Disease Management
The Centre Hospitalier General De Soissons is actively engaged in advancing antimicrobial stewardship and infectious disease management in geriatric populations. The center focuses on optimizing therapeutic approaches through evidence-based research aimed at improving patient outcomes while addressing the critical issue of antibiotic resistance.
- Antibiotic stewardship programs in elderly hospitalized patients
- Viral pneumonia diagnosis and treatment optimization
- Infectious disease management in geriatric medicine
Through multicenter clinical research, the institution investigates innovative strategies for early discontinuation of antibiotic therapy in cases of viral infections, particularly focusing on reducing unnecessary antibiotic consumption. This work contributes to the broader effort of combating antimicrobial resistance while ensuring appropriate care for elderly patients hospitalized with respiratory infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier General De Soissons
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Adjuvant Pembrolizumab Versus Observation in Early Triple-Negative Breast Cancer with Pathologic Complete Response Post-Neoadjuvant Therapy | Unicancer | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin Sodium | 1 | Unknown | 2026-02-02 | 2026-02-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.